
Moonwalk Biosciences Closes Oversubscribed $70 Million Series B
South San Francisco-based Moonwalk Biosciences has closed an oversubscribed $70 million Series B financing, extending investor interest in the company's biotechnology platform amid continued strong venture capital appetite for well-differentiated life sciences companies.








